We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTS icon
1051
Sensus Healthcare
SRTS
$50.5M
$289K 0.01%
23,100
-12,000
-34% -$143K
DTIL icon
1052
Precision BioSciences
DTIL
$207M
$288K 0.01%
+7,383
New +$351K
ELVN icon
1053
Enliven Therapeutics
ELVN
$4.43B
$288K 0.01%
31,625
RDW icon
1054
Redwire
RDW
$3.25B
$288K 0.01%
+121,000
New +$373K
WLMS
1055
DELISTED
Williams Industrial Services Group Inc.
WLMS
$288K 0.01%
194,500
IMUX icon
1056
Immunic
IMUX
$195M
$287K 0.01%
9,080
+5,300
+140% +$222K
IDN icon
1057
Intellicheck
IDN
$79.6M
$286K 0.01%
113,300
-50,000
-31% -$129K
LYRA
1058
DELISTED
LYRA THERAPEUTICS INC
LYRA
$285K 0.01%
1,138
CDMO
1059
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$285K 0.01%
14,900
ADVM
1060
DELISTED
Adverum Biotechnologies
ADVM
$284K 0.01%
29,900
+5,700
+24% +$74.9K
CPHC icon
1061
Canterbury Park Holding Corp
CPHC
$80M
$283K 0.01%
12,689
CULP icon
1062
Culp Inc
CULP
$44.1M
$283K 0.01%
64,900
-40,000
-38% -$189K
LUCD icon
1063
Lucid Diagnostics
LUCD
$184M
$283K 0.01%
185,000
GIFI
1064
DELISTED
Gulf Island Fabrication
GIFI
$280K 0.01%
67,148
-15,900
-19% -$59.1K
HALL
1065
DELISTED
Hallmark Financial Services, Inc.
HALL
$279K 0.01%
26,560
OMCL icon
1066
Omnicell
OMCL
$1.68B
$278K 0.01%
3,200
SGRP
1067
DELISTED
SPAR Group
SGRP
$278K 0.01%
191,437
-3,200
-2% -$4.13K
PATI
1068
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$274K 0.01%
34,871
LCTX icon
1069
Lineage Cell Therapeutics
LCTX
$278M
$273K 0.01%
241,666
-152,700
-39% -$224K
RAIL icon
1070
FreightCar America
RAIL
$260M
$272K 0.01%
73,000
-9,000
-11% -$37.6K
TSHA icon
1071
Taysha Gene Therapies
TSHA
$1.89B
$270K 0.01%
139,869
+69,060
+98% +$251K
BOXD
1072
DELISTED
Boxed, Inc.
BOXD
$270K 0.01%
+292,500
New +$427K
EVER icon
1073
EverQuote
EVER
$906M
$269K 0.01%
+39,500
New +$370K
HOOK
1074
DELISTED
HOOKIPA Pharma
HOOK
$269K 0.01%
20,080
+12,350
+160% +$190K
SYY icon
1075
Sysco
SYY
$40.3B
$269K 0.01%
3,800

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.